Back to all stories

FDA approves libido drug for postmenopausal women

The U.S. Food and Drug Administration approved a prescription pill intended to boost sexual desire in women who have gone through menopause. The nationwide approval means Twin Cities clinicians can consider the new therapy for eligible patients once distribution begins, subject to prescribing guidance and labeling.

Health
This story is compiled from 1 source using AI-assisted curation and analysis. Original reporting is attributed below. Learn about our methodology.

📌 Key Facts

  • Regulator: U.S. Food and Drug Administration
  • Action: Approval of a libido‑boosting pill for postmenopausal women
  • Date: Dec. 15, 2025; approval applies nationwide, including Minnesota

📰 Source Timeline (1)

Follow how coverage of this story developed over time

December 15, 2025